Fulgent Genetics Inc. (FLGT) is scheduled to report third-quarter 2025 financial results before the market opens today, November 7, 2025.
This technology-based company operates in two segments - a well-established laboratory services business and a therapeutic development business.
The laboratory services business includes technical laboratory and testing services, and professional interpretation of laboratory results by licensed physicians. This segment generates revenue from molecular testing, including precision diagnostics and anatomic pathology, BioPharma services, and COVID-19 testing.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.